79 related articles for article (PubMed ID: 30591535)
1. Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.
Walter JE; Heuvelmans MA; Ten Haaf K; Vliegenthart R; van der Aalst CM; Yousaf-Khan U; van Ooijen PMA; Nackaerts K; Groen HJM; De Bock GH; de Koning HJ; Oudkerk M
Thorax; 2019 Mar; 74(3):247-253. PubMed ID: 30591535
[TBL] [Abstract][Full Text] [Related]
2. The role of computer-assisted radiographer reporting in lung cancer screening programmes.
Hall H; Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Batty J; Woznitza N; Ahmed A; Burke S; Shaw P; Soo MJ; Taylor M; Navani N; Bhowmik A; Baldwin DR; Duffy SW; Devaraj A; Nair A; Janes SM
Eur Radiol; 2022 Oct; 32(10):6891-6899. PubMed ID: 35567604
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results of low-dose computed tomography screening for lung cancer in asymptomatic participants.
Deng Y; Xiong Z; Mao X; Zhou L; Guo F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):244-251. PubMed ID: 35545415
[TBL] [Abstract][Full Text] [Related]
4. Results of the two incidence screenings in the National Lung Screening Trial.
Aberle DR; DeMello S; Berg CD; Black WC; Brewer B; Church TR; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gatsonis CA; Gierada DS; Jain A; Jones GC; Mahon I; Marcus PM; Rathmell JM; Sicks J;
N Engl J Med; 2013 Sep; 369(10):920-31. PubMed ID: 24004119
[TBL] [Abstract][Full Text] [Related]
5. Who is at risk of lung nodules on low-dose CT in a Western country? A population-based approach.
Cai J; Vonder M; Du Y; Pelgrim GJ; Rook M; Kramer G; Groen HJM; Vliegenthart R; de Bock GH
Eur Respir J; 2024 Jun; 63(6):. PubMed ID: 38697647
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and burden of bronchiectasis in a lung cancer screening program.
Sanchez-Carpintero Abad M; Sanchez-Salcedo P; de-Torres JP; Alcaide AB; Seijo LM; Pueyo J; Bastarrika G; Zulueta JJ; Campo A
PLoS One; 2020; 15(4):e0231204. PubMed ID: 32282811
[TBL] [Abstract][Full Text] [Related]
7. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program.
Robbins HA; Alcala K; Moez EK; Guida F; Thomas S; Zahed H; Warkentin MT; Smith-Byrne K; Brhane Y; Muller D; Feng X; Albanes D; Aldrich MC; Arslan AA; Bassett J; Berg CD; Cai Q; Chen C; Davies MPA; Diergaarde B; Field JK; Freedman ND; Huang WY; Johansson M; Jones M; Koh WP; Lam S; Lan Q; Langhammer A; Liao LM; Liu G; Malekzadeh R; Milne RL; Montuenga LM; Rohan T; Sesso HD; Severi G; Sheikh M; Sinha R; Shu XO; Stevens VL; Tammemägi MC; Tinker LF; Visvanathan K; Wang Y; Wang R; Weinstein SJ; White E; Wilson D; Yuan JM; Zhang X; Zheng W; Amos CI; Brennan P; Johansson M; Hung RJ
Ann Epidemiol; 2023 Jan; 77():1-12. PubMed ID: 36404465
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the stage shift growth of early-stage lung adenocarcinomas by volume-doubling time.
Tang EK; Wu YJ; Chen CS; Wu FZ
Quant Imaging Med Surg; 2024 Jun; 14(6):3983-3996. PubMed ID: 38846271
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules.
Hu K; Gao L; Zhang R; Lu M; Zhou D; Xie S; Fan X; Zhu M
Heliyon; 2024 May; 10(9):e30576. PubMed ID: 38765082
[TBL] [Abstract][Full Text] [Related]
10. Screening approaches for lung cancer by blood-based biomarkers: Challenges and opportunities.
van den Broek D; Groen HJM
Tumour Biol; 2024; 46(s1):S65-S80. PubMed ID: 37393461
[TBL] [Abstract][Full Text] [Related]
11. Detection of the DNA methylation of seven genes contribute to the early diagnosis of lung cancer.
Du C; Tan L; Xiao X; Xin B; Xiong H; Zhang Y; Ke Z; Yin J
J Cancer Res Clin Oncol; 2024 Feb; 150(2):77. PubMed ID: 38315228
[TBL] [Abstract][Full Text] [Related]
12. Validation of multivariable lung cancer risk prediction models for the personalized assignment of optimal screening frequency: a retrospective analysis of data from the German Lung Cancer Screening Intervention Trial (LUSI).
González Maldonado S; Hynes LC; Motsch E; Heussel CP; Kauczor HU; Robbins HA; Delorme S; Kaaks R
Transl Lung Cancer Res; 2021 Mar; 10(3):1305-1317. PubMed ID: 33889511
[TBL] [Abstract][Full Text] [Related]
13. Association of Lung Cancer Risk With the Presence of Both Lung Nodules and Emphysema in a Lung Cancer Screening Trial.
Liu Y; Feng ZW; Liu XM; Duan HY; Lyu ZY; Huang YB; Song FF; Song FJ
World J Oncol; 2024 Apr; 15(2):246-256. PubMed ID: 38545483
[TBL] [Abstract][Full Text] [Related]
14. Personalised follow-up and management schema for patients with screen-detected pulmonary nodules: A dynamic modelling study.
Wang Z; Xue F; Sui X; Han W; Song W; Jiang J
Pulmonology; 2024 Apr; ():. PubMed ID: 38614860
[TBL] [Abstract][Full Text] [Related]
15. Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption.
Poon C; Wilsdon T; Sarwar I; Roediger A; Yuan M
Front Public Health; 2023; 11():1264342. PubMed ID: 38026274
[TBL] [Abstract][Full Text] [Related]
16. Measuring Lung Nodules on Lung Cancer Screening CT: Point-Volumetric Measurement Aids Detection of Nodule Growth.
Byrne SC; Hammer MM
AJR Am J Roentgenol; 2024 Jun; ():. PubMed ID: 38864702
[No Abstract] [Full Text] [Related]
17. Measuring Lung Nodules on Lung Cancer Screening CT: Counterpoint-Mean Diameters Measure Up!
Christensen JD
AJR Am J Roentgenol; 2024 Jun; ():. PubMed ID: 38864700
[No Abstract] [Full Text] [Related]
18. Optimizing lung cancer screening: nodule size, volume doubling time, morphology and evaluation of other diseases.
Mohamed Hoesein FA; de Jong PA; Mets OM
Ann Transl Med; 2015 Feb; 3(2):19. PubMed ID: 25738139
[No Abstract] [Full Text] [Related]
19. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials.
Jolliffe DA; Greenberg L; Hooper RL; Mathyssen C; Rafiq R; de Jongh RT; Camargo CA; Griffiths CJ; Janssens W; Martineau AR
Thorax; 2019 Apr; 74(4):337-345. PubMed ID: 30630893
[TBL] [Abstract][Full Text] [Related]
20. Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective.
Wang GX; Baggett TP; Pandharipande PV; Park ER; Percac-Lima S; Shepard JO; Fintelmann FJ; Flores EJ
Radiology; 2019 Feb; 290(2):278-287. PubMed ID: 30620258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
